AzTrials
AzTrials

Blood FlowBAMBINCT06886698

MRI Assesment of Cerebral Blood Flow in Anesthetized Children

An observational study of Blood Flow and Cerebral Oxygenation, run by Karolinska Institutet at 1 site in Sweden.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Children undergoing magnetic resonance imaging (MRI) of the brain often need to be sedated to complete the examination, as it is difficult to remain still for a long period, which is required to obtain usable images. During sedation, most patients typically experience a drop in blood pressure, including children. Read more about this study

Who is it for?
Ages 6 months to 12 years
Conditions the study is for
Blood Flow, Cerebral Oxygenation, Blood Pressure
How many people
30 participants
Where
1 siteSweden
Study dates
15 Apr 2025to 15 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients scheduled for brain MRI under anesthesia, aged 6 months to 12 years

Who may be able to join

  • children aged 6 months to 12 years
  • Planned to undergo MRI brain

Who cannot join

  • known brain tumor
  • vascular malformation in the brain
  • hydrocephalus

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jacob Karlsson, MD PhD Associate Professor contact

+46737145217

jacob.karlsson.1@ki.se

Per-Arne Lönnqvist, Professor contact

+46812370000

per-arne.lönnqvist@ki.se

Sweden1 site
  • Karolinska University Hospital

    Solna, 171 64

    Peter Larsson, MD PhD, +46812370000, peter.larsson@regionstockholm.se

    Titus Schlinzig, MD PhD, +46812370000, titus.schlinzig@regionstockholm.se

Other trials in Sweden

About this study

Official title: Arterial Spin Label Assessment of Cerebral Blood Flow in Anesthetized Children

Children undergoing magnetic resonance imaging (MRI) of the brain often need to be sedated to complete the examination, as it is difficult to remain still for a long period, which is required to obtain usable images. During sedation, most patients typically experience a drop in blood pressure, including children. Maintaining an adequate blood pressure under anesthesia is important, as blood pressure is routinely used as a measure to ensure sufficient blood circulation to the body's organs, including the brain. Ensuring adequate blood flow to the brain is one of the cornerstones of all anesthesia, including in children. Therefore, low blood pressure during anesthesia is often treated with standardized interventions, such as blood pressure-raising interventions. These treatments generally restore blood pressure to normal, but how this affects blood flow to the brain in children is not fully known.

With the help of modern MRI technology (so-called Arterial Spin Labeling, ASL), blood flow in the brain can be measured quickly and completely safely with high precision.

Read more

In similar situations with adult patients, it has been observed that while blood pressure-raising interventions successfully normalize low blood pressure, MRI scans show that blood flow to the brain paradoxically decreases despite the increase in blood pressure. It is believed that this may be due to the brain's blood vessels constricting.

The investigators now wish to examine this relationship in sedated children undergoing planned brain MRI for certain diagnoses. The investigators hypothesis is that standardized measures intended to raise blood pressure (i.e., the routine treatment used regardless of whether a patient participates in the study or not) normalizes low blood pressure (when deemed necessary to treat according to routine) but does not necessarily lead to improved blood flow to the brain.

Primary research question: How does routine treatment of low blood pressure affect cerebral blood flow in sedated children?

Read the detailed description

Patients undergoing sedation for brain MRI will be identified based on the surgical schedule . If no exclusion criteria are met, the child will be eligible for inclusion in the study, and both the child and their guardians will be informed, with consent requested and obtained.

Basic data regarding the patient's health status, age, sex, and weight will be collected and stored on a dedicated research computer.

The anesthesia procedure for MRI examinations routinely involves measuring blood pressure before administering premedication. A peripheral venous catheter (PVC) is then placed, after which the child is sedated with a propofol infusion (an anesthetic drug). Oxygen is routinely provided via nasal cannula. Standard monitoring includes heart rate, blood pressure, and blood oxygen saturation. All study participants will be prepared, sedated, and monitored according to this standard procedure, exactly as would be done regardless of whether they participate in the study or not.

Once the child is placed in the MRI scanner, the examination proceeds as per routine. Blood pressure is measured every five minutes. As soon as the mean arterial pressure (MAP) drops by more than 20% from baseline (i.e., the blood pressure measured when the patient was awake), brain blood flow measurement using an ASL sequence in the MRI machine will begin. ASL, or Arterial Spin Labeling, is a safe MRI technique for measuring cerebral blood flow without the need for contrast injection. This method magnetically "labels" the blood and then tracks its movement into the brain, providing valuable information about cerebral perfusion. ASL is already routinely used in children undergoing MRI for conditions such as epilepsy, brain tumors, and headaches.

The ASL sequence will be initiated immediately upon detecting the blood pressure drop. Subsequently, blood pressure will be managed according to clinical routine (this management will be performed regardless of study participation), and brain blood flow will be recorded during the ASL sequence. Clinical routine management primarily involves administering intravenous blood pressure-raising medications. The ASL sequence itself takes approximately 12 minutes. Once the study protocol is completed, the MRI examination and anesthesia/monitoring will continue as per routine until completion.

Data collected from the ASL scans will then be processed using specialized software for further analysis. ASL recording will begin upon detecting a >20% drop in blood pressure, after which blood pressure will be treated according to routine. Normally, no pre-prepared blood pressure treatment is available, meaning it must be prepared at the time (e.g., blood pressure-raising medication). This preparation is estimated to take approximately 3 minutes, so the additional 12-minute sequence effectively extends the MRI duration by about (12-3) = 9 minutes (practically, this is expected to add around 10-15 extra minutes). In context, this additional time is negligible for the patient, as time windows of 10-15 minutes are common during MRI, for example, when waiting for image interpretation or adding new sequences (such as ASL, which is sometimes included for additional information, regardless of study participation).

The study will not result in an increased number of visits for research participants

Keywords
anesthesia, bloodflow, brain, children

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06886698
Study groupRoleWhat they receive
pediatric MRIPatients scheduled for brain MRI under anesthesia, aged 6 months to 12 years.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in cerebral blood flow in response to hypotension treatment

    Quantification of cerebral blood flow using Arterial Spin Labeling during hypotension and subsequently in response to standardized treatment of hypotension as per departmental standard operating procedure.

    Measured: From detection of hypotension to assessment of immediate change in cebrebral bloodflow, data reported after approximately one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2025
  2. Study start15 Apr 2025 (estimated)
  3. Primary completion15 Apr 2026 (estimated)
  4. Study completion15 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06886698
Sponsor's protocol ID
K 2025-0337
Other IDs
Region Stockholm
Acronym
BAMBI
Status last verified
Mar 2025
First submitted
13 Mar 2025
Last updated
25 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Blood Flow and Cerebral Oxygenation, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jacob Karlsson, MD PhD Associate Professor (+46737145217, jacob.karlsson.1@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in cerebral blood flow in response to hypotension treatment (time frame: From detection of hypotension to assessment of immediate change in cebrebral bloodflow, data reported after approximately one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in